A combined approach based on drug cyclodextrin (CD) complexation and loading into PLGA nanoparticles (NP) has been developed to improve oxaprozin therapeutic efficiency. This strategy exploits the solubilizing and stabilizing properties of CDs and the prolonged-release and targeting properties of PLGA NPs. Drug-loaded NPs, prepared by double-emulsion, were examined for dimensions, zeta-potential and entrapment efficiency. Solid-state studies demonstrated the absence of drug-polymer interactions and assessed the amorphous state of the drug-CD complex loaded into NPs. Drug release rate from NPs was strongly influenced by the presence and kind of CD used. The percentage released at 24 h varied from 16% (plain drug-loaded NPs) to 50% (drug-betaCD-loaded NPs) up to 100% (drug-methylbetaCD-loaded NPs). This result suggests the possibility of using CD complexation not only to promote, but also to regulate drug release rate from NPs, by selecting the proper type of CD or CD combination.

Development of a new delivery system consisting in ‘drug–in cyclodextrin–in PLGA nanoparticles’ / P.Mura; F.Maestrelli; M.Cecchi; M.Bragagni; A.Almeida. - In: JOURNAL OF MICROENCAPSULATION. - ISSN 0265-2048. - ELETTRONICO. - 27(2010), pp. 479-486. [10.3109/02652040903515508]

Development of a new delivery system consisting in ‘drug–in cyclodextrin–in PLGA nanoparticles’

MURA, PAOLA ANGELA;MAESTRELLI, FRANCESCA;
2010

Abstract

A combined approach based on drug cyclodextrin (CD) complexation and loading into PLGA nanoparticles (NP) has been developed to improve oxaprozin therapeutic efficiency. This strategy exploits the solubilizing and stabilizing properties of CDs and the prolonged-release and targeting properties of PLGA NPs. Drug-loaded NPs, prepared by double-emulsion, were examined for dimensions, zeta-potential and entrapment efficiency. Solid-state studies demonstrated the absence of drug-polymer interactions and assessed the amorphous state of the drug-CD complex loaded into NPs. Drug release rate from NPs was strongly influenced by the presence and kind of CD used. The percentage released at 24 h varied from 16% (plain drug-loaded NPs) to 50% (drug-betaCD-loaded NPs) up to 100% (drug-methylbetaCD-loaded NPs). This result suggests the possibility of using CD complexation not only to promote, but also to regulate drug release rate from NPs, by selecting the proper type of CD or CD combination.
27
479
486
P.Mura; F.Maestrelli; M.Cecchi; M.Bragagni; A.Almeida
File in questo prodotto:
File Dimensione Formato  
Mura et al., 2010.pdf

Accesso chiuso

Descrizione: ARTICOLO
Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 649.52 kB
Formato Adobe PDF
649.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2158/389488
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 18
social impact